Market Access/ R&D/ Views & Analysis/ Views & Analysis/ Views and analysis Evaluate’s Orphan Drug Report shows rapid acceleration in the space Jessica Hagen Andreas Hadjivasiliou, Evaluate, Orphan Drug Report, orphan drugs, Paul Verdin 0 Comment Paul Verdin, VP of consulting and analytics, and Andreas Hadjivasiliou, managing analyst at Evaluate, tell us about the Share X Evaluate’s Orphan Drug Report shows rapid acceleration in the space https://pharmaphorum.com/market-access-2/evaluates-orphan-drug-report-2022/